Enlivex Therapeutics Ltd. Current Ratio 2011-2026 | ENLV

Annual Current Ratio Enlivex Therapeutics Ltd.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
6.76	5.46	6.26	9.41	8.29	2.8	8.31	-	-	8.11	14.4	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
14.4	2.8	7.76

Quarterly Current Ratio Enlivex Therapeutics Ltd.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	9.41	-	19.1	-	8.29	-	6.76	-	2.8	-	-	-	8.31	-	-	-	3.46	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
19.1	2.8	8.31

Current Ratio of other stocks in the Biotechnology industry

Issuer	Current Ratio	Price	% 24h	Market Cap	Country
Aquestive Therapeutics AQST	0.827	$ 4.12	-0.36 %	$ 441 M	USA
MorphoSys AG MOR	1.02	-	2.43 %	$ 254 M	Germany
Arcturus Therapeutics Holdings ARCT	4.74	$ 8.32	3.67 %	$ 228 M	Israel
Arcutis Biotherapeutics ARQT	1.78	$ 23.65	0.08 %	$ 3.01 B	USA
BioVie BIVI	8.46	$ 1.46	2.82 %	$ 2.16 M	USA
BioLineRx Ltd. BLRX	1.53	$ 2.32	4.98 %	$ 908 M	Israel
BioNTech SE BNTX	7.95	$ 91.44	0.29 %	$ 27.2 B	Germany
I-Mab IMAB	8.96	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	3.59	-	-	$ 40.3 B	USA
Genfit SA GNFT	0.922	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	1.34	-	-13.47 %	$ 169 M	France
BioXcel Therapeutics BTAI	0.32	$ 1.16	-2.12 %	$ 14.2 M	USA
Midatech Pharma plc MTP	2.29	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	1.02	-	-1.52 %	$ 24.7 M	USA
Burford Capital Limited BUR	2.14	$ 4.52	9.18 %	$ 683 M	Britain
Acorda Therapeutics ACOR	1.61	-	-24.86 %	$ 820 K	USA
Cabaletta Bio CABA	3.11	$ 3.1	4.56 %	$ 311 M	USA
Adverum Biotechnologies ADVM	1.65	-	-	$ 86.2 M	USA
Can-Fite BioPharma Ltd. CANF	2.76	$ 3.17	1.44 %	$ 6.9 B	Israel
Advaxis ADXS	5.93	-	-9.65 %	$ 45.9 M	USA
Applied Molecular Transport AMTI	2.31	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	1.6	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	0.995	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	2.59	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	12.4	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.79	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	10.9	-	-	$ 3.67 B	USA
Akouos AKUS	6.18	-	0.23 %	$ 488 M	USA
Catalyst Biosciences CBIO	6.97	$ 19.48	0.39 %	$ 1.74 B	USA
Институт стволовых клеток человека ISKJ	1.04	-	-	-	Russia
Allena Pharmaceuticals ALNA	2.19	-	3.16 %	$ 1.9 M	USA
Codexis CDXS	1.52	$ 1.95	6.87 %	$ 170 M	USA
Alpine Immune Sciences ALPN	2.67	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	3.34	-	10.36 %	$ 9.8 M	USA
Anavex Life Sciences Corp. AVXL	11.6	$ 3.01	0.67 %	$ 257 M	USA
Cerus Corporation CERS	1.41	$ 1.91	2.69 %	$ 364 M	USA
Cullinan Management CGEM	11.3	$ 15.11	4.71 %	$ 910 M	USA
Coherus BioSciences CHRS	1.31	$ 1.72	-0.87 %	$ 201 M	USA
CollPlant Biotechnologies Ltd. CLGN	3.57	$ 0.46	-13.02 %	$ 5.27 M	Israel
Aravive ARAV	1.21	-	-13.39 %	$ 1.45 M	USA
Aptose Biosciences APTO	0.269	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	2.35	-	-39.0 %	$ 4.57 M	USA
CNS Pharmaceuticals CNSP	2.1	$ 2.25	-0.44 %	$ 998 K	USA
CureVac N.V. CVAC	2.47	-	-	$ 867 M	Germany
AstraZeneca PLC AZN	1.75	-	-	$ 96.9 B	Britain
Catalyst Pharmaceuticals CPRX	7.37	$ 24.95	1.05 %	$ 3.05 B	USA
Celldex Therapeutics CLDX	10.4	$ 31.33	0.85 %	$ 2.08 B	USA
Corbus Pharmaceuticals Holdings CRBP	8.13	$ 10.27	0.98 %	$ 137 M	USA
Cardiff Oncology CRDF	3.75	$ 1.6	1.27 %	$ 107 M	USA
Avenue Therapeutics ATXI	2.67	-	-52.27 %	$ 4.45 M	USA